ICAM1 and neoplasm: Analyses of primary tumors from patients with breast cancer revealed a negative correlation of ICAM-1 expression to tumor size, lymph node metastasis and tumor infiltration as well as a better relapse-free and overall survival in patients with ICAM-1-positive tumors than in those with negative tumors [27].